Financial Highlights - Total revenue grew by 13% YoY, with an improvement of 840 bps[5] - Q3 2025 total revenue reached $197 million, a 30% increase YoY[9] - Surgical revenue reached $177 million, a 31% increase YoY[9] - EOS revenue reached $20 million, a 29% increase YoY[9] - Gross margin was 70%, an increase of 80 bps[9] - Operating margin was 5%, an increase of 1,150 bps[9] - Non-GAAP net income was $4 million[9] - Adjusted EBITDA was $26 million, an increase of $19 million, representing 13% of sales, an increase of 840 bps[12] - Trailing 12-month Adjusted EBITDA reached $81 million[12] - Free cash flow was $5 million[15]